Detalhe da pesquisa
1.
Tumor Growth Rate Informs Treatment Efficacy in Metastatic Pancreatic Adenocarcinoma: Application of a Growth and Regression Model to Pivotal Trial and Real-World Data.
Oncologist;
28(2): 139-148, 2023 02 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36367377
2.
Chemotherapy (doublet or triplet) plus targeted therapy by RAS status as conversion therapy in colorectal cancer patients with initially unresectable liver-only metastases. The UNICANCER PRODIGE-14 randomised clinical trial.
Br J Cancer;
126(9): 1264-1270, 2022 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34992255
3.
Phase II study evaluating the association of gemcitabine, trastuzumab and erlotinib as first-line treatment in patients with metastatic pancreatic adenocarcinoma (GATE 1).
Int J Cancer;
148(3): 682-691, 2021 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33405269
4.
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
N Engl J Med;
379(25): 2395-2406, 2018 12 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30575490
5.
FOLFIRINOX-R study design: a phase I/II trial of FOLFIRINOX plus regorafenib as first line therapy in patients with unresectable RAS-mutated metastatic colorectal cancer.
BMC Cancer;
21(1): 564, 2021 May 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34001059
6.
Sorafenib alone vs. sorafenib plus GEMOX as 1st-line treatment for advanced HCC: the phase II randomised PRODIGE 10 trial.
Br J Cancer;
120(9): 896-902, 2019 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30944458
7.
Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study.
Oncologist;
24(2): 185-192, 2019 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30190299
8.
Comparison of early radiological predictors of outcome in patients with colorectal cancer with unresectable hepatic metastases treated with bevacizumab.
Gut;
67(6): 1095-1102, 2018 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29084828
9.
Multiple Hotspot Mutations Scanning by Single Droplet Digital PCR.
Clin Chem;
64(2): 317-328, 2018 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29122835
10.
Retrospective Analysis of CA19-9 Decrease in Patients with Metastatic Pancreatic Carcinoma Treated with FOLFIRINOX or Gemcitabine in a Randomized Phase III Study (ACCORD11/PRODIGE4).
Oncology;
93(6): 367-376, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28982109
11.
Imaged-guided liver stereotactic body radiotherapy using VMAT and real-time adaptive tumor gating. Concerns about technique and preliminary clinical results.
Rep Pract Oncol Radiother;
22(2): 141-149, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28490985
12.
SBRT planning for liver metastases: A focus on immobilization, motion management and planning imaging techniques.
Rep Pract Oncol Radiother;
22(2): 103-110, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28490980
13.
Reproductive Decision-Making in MMR Mutation Carriers After Results Disclosure: Impact of Psychological Status in Childbearing Options.
J Genet Couns;
25(3): 432-42, 2016 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26392361
14.
Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial.
Lancet Oncol;
16(8): 937-48, 2015 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26184520
15.
Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial.
Lancet;
381(9863): 303-12, 2013 Jan 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23177514
16.
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer.
N Engl J Med;
364(19): 1817-25, 2011 May 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21561347
17.
Biweekly docetaxel, fluorouracil, leucovorin, oxaliplatin (TEF) as first-line treatment for advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: safety and efficacy in a multicenter cohort.
Gastric Cancer;
17(2): 341-7, 2014 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23739764
18.
Triplet chemotherapy plus cetuximab as first-line treatment in extended RAS wild-type metastatic colorectal cancer patients.
Dig Liver Dis;
2024 Jan 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38233313
19.
A randomized phase II trial of three intensified chemotherapy regimens in first-line treatment of colorectal cancer patients with initially unresectable or not optimally resectable liver metastases. The METHEP trial.
Ann Surg Oncol;
20(13): 4289-97, 2013 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23955585
20.
The role of the FOLFIRINOX regimen for advanced pancreatic cancer.
Curr Oncol Rep;
15(2): 182-9, 2013 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23341367